Results 11 to 20 of about 195,915 (258)
MicroRNAs in Diabetic Kidney Disease [PDF]
International Journal of Endocrinology, 2014 Rapid growth of diabetes and diabetic kidney disease exerts a great burden on society. Owing to the lack of effective treatments for diabetic kidney disease, treatment relies on drugs that either reduces its progression or involve renal replacement ...
Rong Li +3 more
doaj +3 more sources
Pathomechanisms of Diabetic Kidney Disease [PDF]
Journal of Clinical Medicine, 2023 The worldwide occurrence of diabetic kidney disease (DKD) is swiftly rising, primarily attributed to the growing population of individuals affected by type 2 diabetes. This surge has been transformed into a substantial global concern, placing additional strain on healthcare systems already grappling with significant demands.
Satyesh K. Sinha, Susanne B. Nicholas
openaire +3 more sources
Inflammation and Diabetic Kidney Disease. [PDF]
Int J Mol SciDiabetes is the leading cause of end-stage kidney disease and significantly contributes to morbidity and mortality in people with diabetes. Despite significant advances in the last decade, including the development of novel therapies, the residual risk in diabetic kidney disease (DKD) remains high.
Zhang RM, Caramori ML.
europepmc +3 more sources
Clinical Journal of the American Society of Nephrology, 2017 Diabetic kidney disease (DKD) is a major cause of ESRD. Management includes prudent BP and glycemic control, nutritional counseling, and lifestyle modifications, including exercise, weight loss, and smoking cessation. Renin-angiotensin system (RAS) blockade using angiotensin-converting enzyme (ACE)
Lili, Tong, Sharon G, Adler
openaire +2 more sources
The Vascular Disease of Diabetic Kidney Disease
Cardiorenal Medicine, 2022 <b><i>Background:</i></b> The incidence of cardiovascular disease (CVD) is increased in patients with diabetic kidney disease (DKD). <b><i>Summary:</i></b> Aortic stiffness is a well-accepted biomarker for cardiovascular (CV) events in all stages of CKD.
Paolo Lentini +9 more
openaire +4 more sources
Mitophagy in Diabetic Kidney Disease [PDF]
Frontiers in Cell and Developmental Biology, 2021 Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease worldwide and is the main microvascular complication of diabetes. The increasing prevalence of diabetes has increased the need for effective treatment of DKD and identification of new therapeutic targets for better clinical management.
Xiaofeng Zhang +6 more
openaire +3 more sources
Pathophysiology of Diabetic Kidney Disease
European Medical Journal Nephrology, 2022 Diabetic kidney disease (DKD) has been an immense burden on the healthcare system, and is the leading cause of end stage kidney disease worldwide. DKD involves various intersecting pathways that lead to progressive kidney damage.
Moarij Qaz +4 more
doaj +1 more source
BMC Nephrology, 2023 Background Diabetic kidney disease (DKD) is the most common microvascular complication of diabetes, which has been a major cause of end-stage renal failure.
Xue-hong Zhou +4 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Introduction: Qing-Re-Xiao-Zheng-Yi-Qi Formula is an effective prescription in diabetic kidney disease treatment, we have confirmed the efficacy of Qing-Re-Xiao-Zheng therapy in diabetic kidney disease through clinical trials.
Qiaoru Wu +8 more
doaj +1 more source
Swiss Medical Weekly, 2023 Diabetic kidney disease is highly prevalent in patients with type 2 diabetes and is a major cause of end-stage renal disease in Switzerland. Patients with diabetic kidney disease are among the most complex patients in diabetes care.
Anne Zanchi +7 more
doaj +1 more source